NeoGenomics, Inc. (NEO)
SERVICES-TESTING LABORATORIES
NeoGenomics, Inc. (NEO) is listed on Nasdaq, where it has traded since January 25, 1996.
- Listed On
- Nasdaq
- Listed Since
- January 25, 1996
- Employees
- 2,500
- Market Cap
- $2.3B
About NeoGenomics, Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 259 institutions reported holding NEO, with 145.0 million shares worth $2.1 billion in aggregate. The largest reported holder was BlackRock, with 20.9 million shares worth $304.5 million. Of the 5 largest holders listed below, 4 added shares and 1 reduced its position during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| BlackRock | 20,868,362 | $304M | Added 4.56% |
| Vanguard | 14,873,941 | $217M | Added 4.1% |
| First Light Asset Management | 12,279,523 | $179M | Added 26.2% |
| First Trust Advisors | 10,113,261 | $148M | Added 64.11% |
| Greenhouse Funds Lllp | 8,574,210 | $125M | Reduced 5.78% |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is NEO?
NeoGenomics, Inc. (NEO) is listed on Nasdaq, where it has traded since January 25, 1996.
Who are the largest institutional holders of NEO?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of NEO were BlackRock, Vanguard and First Light Asset Management.
How many institutions own NEO?
259 institutions reported a position in NEO for the quarter ended June 30, 2026, worth $2.1 billion in total.
Did institutions buy or sell NEO last quarter?
Of the 5 largest reported holders, 4 added shares and 1 reduced its position during the quarter. Every reported holder and its change is on the SentiSense ownership page for NEO.
Every reported institutional holder, plus insider and congressional trades in NEO, on SentiSense.